News and Announcements
Income2Wealth Armchair Investor Community Received $2.1M
- Published April 07, 2022 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Our proactive Development Team continue to deliver stylish contemporary homes via The Mills Master Plan for Tasmanian locals. Meanwhile our Armchair Developer Community continue to enjoy solid and reliable monthly returns into their bank accounts and SMSF’s each and every month.
Following on from last months capital return, the March distribution our Armchair Investor Community received totalled $2,108,767.
That’s a total of just over $37 Million paid in Monthly Distributions to our Investor Community since 2018 and 100% of Due Capital On Completed Investments Returned.
If you’d like to discover more about our Armchair Investment Options, please call Income2Wealth’s office on 1800600890 or email [email protected].
You should consider the information and associated risks in the Disclosure Documents in full before making any kind of investment decision. Investment products offered by I2W are not bank deposits. Past performance is not an indicator of future performance.
About The Company
At Income2Wealth we understand how difficult it can be to tune out the clutter of everyday demands, emotions and the varied opinions that can cloud your investment decisions. It’s easy to become overwhelmed listening to the conflicting investment strategies proposed by your friends, your family and various industry ‘experts’. We want to help you build the confidence and clarity you need to become a successful investor and we don’t leave anything to chance.
We don’t believe in a cookie cutter approach to investing – not every investment pathway is suited to every investor.
At Income2Wealth, our focus is on providing a wide variety of investment pathways aimed at helping you achieve your goals on your budget and in your timeframe.
Company Updates
The System’s Immune System: Why Big Tech Will Solve What Big Pharma Can’t
The central investment thesis for the future of human health pits Big Pharma against Big Tech. This blog post explores the “Protocol Paradox” in current cancer care and argues that the convergence of hyperscalers and life-science experts—treating biology as a data and compute problem—represents the defining compounding investment opportunity of this era.
The Life Sciences Supercycle: Why Australian Biotech is Finally Delivering Billion-Dollar Outcomes
Australia’s life sciences sector is experiencing an unprecedented “Supercycle,” finally commercializing world-class research into global, billion-dollar businesses. Learn about the ASX heavyweights, the key drivers (AI, institutional execution, FDA pathway), and the investment opportunity at Emergence 2026.
Following the Billions: Where the Hyperscalers are Betting on the Future
The roadmap for the next decade isn’t hidden in pitch decks—it’s written on the balance sheets of Microsoft, Amazon, and Google. Their collective investment is flowing into three key areas: GPU Chips, AI Factories, and Energy. This foundational buildout signals a $7–$20 trillion economic convergence, where the physical race for infrastructure and energy is paramount. The article also covers the powerful macro case for digital assets in this new era.
Backed By Leading Investment Groups and Family Offices
